查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球基因毒性檢測市場規模、份額和行業趨勢分析報告：按產品、類型、應用（製藥/生物技術、食品行業、化妝品行業）、區域展望和預測2022-2028
市場調查報告書
商品編碼
1155433

全球基因毒性檢測市場規模、份額和行業趨勢分析報告：按產品、類型、應用（製藥/生物技術、食品行業、化妝品行業）、區域展望和預測2022-2028

Global Genetic Toxicology Testing Market Size, Share & Industry Trends Analysis Report By Product, By Type, By Application (Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry), By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 199 Pages | 訂單完成後即時交付

價格

到 2028 年，全球基因毒性檢測市場規模預計將達到 24 億美元，預測期內復合年增長率為 13.2%。

此外，這些研究側重於體外藥物發現和定製藥物。除了這些用途之外，對人源化動物模型日益增長的需求將為遺傳毒性測試市場的主要競爭者提供許多機會。遺傳毒性測試用於化妝品、食品、製藥和生物技術行業的各種應用。

由於藥物研究和發現的增加以及藥物基因組學應用的擴大，預計對遺傳毒性信息的需求會增加。這是因為可以評估可能導致染色體損傷和基因改變的物質。遺傳毒性測試領域的一個重要增長因素是全球設施和資金的可用性。

COVID-19 影響分析

製造業停工和因封鎖而實施的旅行限制影響了貨運，而 COVID-19 的迅速傳播導致醫療設備和用品短缺。 COVID-19 並未對基因毒理學中使用的原材料的可用性產生嚴重影響，但由於旅行限制和勞動力短缺導致的與運輸相關的延誤除外。進行了毒性研究以了解病毒突變。此外，許多研究人員正在使用基因毒性來觀察藥物是否對 COVID-19 病毒有效。因此，大流行對遺傳毒性測試市場產生了積極影響。

市場增長因素

企業加大醫藥研發投入

研發活動的主要目的是通過增加臨床前階段物質的吸收來提高 I 期候選治療藥物的接受率。在藥物開發的早期階段，為此積極開展研發活動。因此，越來越需要進行遺傳毒性研究。在藥物進入昂貴的臨床階段之前，早期藥物不斷上升的研發成本預計也將推動體內毒理學技術的使用。

在涉及動物的體內研究中對人性化方法的需求不斷增加

越來越多的生物醫學研究應用正在使用人源化小鼠作為受試者。 2017 年，耶魯大學和傑克遜研究所（美國）的教授獲得了一項為期三年的資助，用於對人源化 MISTRG 模型進行高級研究，以了解人類黑色素瘤的生物學特性，並確定治療靶點。該項目獲得了金獎。康涅狄格生物科學創新基金 (CBIF) 於 2018 年 11 月向傑克遜實驗室和耶魯大學（美國）提供了 700,000 美元的贈款。該獎項支持科學合作，以創建準確反映人類對疾病和癌症治療反應的人性化小鼠模型。

市場約束

複雜終點研究缺乏經過驗證的體外模型

鑑於人類蛋白質和抗體佔所有新藥的一半以上，自身免疫性疾病和免疫激活是藥物開發的關鍵終點。這些藥物仍然只能在動物模型中進行測試。體外遺傳毒性試驗技術不能用於評估繼發感染後在體內引起的反應。也不可能評估身體對短期和長期免疫抑制的恢復能力。

產品展望

基因毒性檢測市場按產品細分為試劑和耗材、化驗和服務。服務部門在 2021 年獲得了基因毒性測試市場最大的收入份額。該領域的擴張是由合同研究組織 (CRO) 通過對該領域的投資不斷增強的戰略雄心推動的。表皮和遺傳毒性檢測服務範圍的擴大也是服務業加速發展的因素之一。例如，Gentronix 宣布將擴大其在皮膚毒性領域的服務範圍，以滿足不斷增長的全球需求。

按類型劃分的前景

遺傳毒性測試市場按類型分為體外和體內。 2021年，基因毒性檢測市場將由體內部分主導。一般來說，醫學研究的一個重要組成部分是體內測試，尤其是在臨床試驗中。體內進行的研究提供了有關物質影響和疾病進展的有用知識。臨床試驗和動物研究是體內研究的兩大類。

應用展望

基因毒性測試市場按應用細分為製藥/生物技術、食品工業、化妝品工業等。 2021 年，製藥和生物技術行業將在基因毒性檢測市場中佔據最大的收入份額。預計增長的驅動因素之一是在藥物開發和研究中廣泛使用遺傳毒性測試。遺傳毒性研究在臨床前階段進行。生物技術和製藥行業預計也將快速增長。鑑於需要測試任何數量的藥物或物質。

區域展望

按地區劃分，對北美、歐洲、亞太地區和 LAMEA 的遺傳毒性測試市場進行了分析。 2021 年，北美地區在基因毒性檢測市場的收入份額最高。該地區的主導地位可歸因於不斷增長的藥物開發和大量的管道支出。此外，該地區主要參與者的存在使得當地製藥和生物技術公司更容易進行基因毒性測試。該行業的很大一部分歸因於基於結構的藥物設計的增長、生命科學研究資金的增加、生物製藥行業的高研發支出以及北美對尖端技術的快速採用。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球基因毒性測試市場，按產品
    • 全球基因毒性測試市場，按類型
    • 全球基因毒性測試市場，按應用分類
    • 全球基因毒性測試市場，按地區劃分
  • 調查方法

第 2 章市場概述

  • 簡介
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動因素
    • 市場製約因素

第 3 章基因毒性測試市場的發展戰略

第 4 章全球基因毒性測試市場：按產品分類

  • 全球服務市場：按地區
  • 按區域劃分的全球試劑和耗材市場
  • 全球檢測市場：按地區

第 5 章全球基因毒性測試市場：按類型分類

  • 全球體外市場：按地區
  • 全球體內市場：按地區

第 6 章全球基因毒性測試市場：按應用

  • 全球製藥和生物技術市場，按地區劃分
  • 全球食品工業市場：按地區
  • 全球化妝品行業市場：按地區
  • 世界其他地區市場

第 7 章。全球基因毒性測試市場：區域市場

  • 北美
    • 按國家/地區劃分的北美基因毒性測試市場
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲遺傳毒性測試市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 亞太地區基因毒性測試的區域市場
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • LAMEA 基因毒性測試市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • LAMEA 的其餘部分

第八章公司簡介

  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific Group
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International, Inc.
  • Jubilant Pharmova Limited
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv, Inc.
  • Creative Bioarray
  • MB Research Laboratories

The Global Genetic Toxicology Testing Market size is expected to reach $2.4 billion by 2028, rising at a market growth of 13.2% CAGR during the forecast period.

The genetic toxicology testing research and observes the consequences of numerous physical, biological, and chemical substances on the heredity of live creatures. Genetic toxicology is the study of the harmful outcomes of DNA damage. These examinations are carried out either to detect chromosomal damage or gene mutation.

Agrochemicals, pharmaceutical impurities, chemicals utilized in the cosmetics industry, pharmaceutical medications, and industrial chemicals are all subjected to toxicological studies. Genetic toxicology is a crucial component of research and development (R&D), where novel medications are developed and designed through a variety of studies. These tests aid in the development of novel medications and vaccinations.

These studies also concentrate on in vitro drug discovery and tailored pharmaceuticals. In addition to these applications, there is a growing need for humanized animal models, which will present a plethora of chances for the major competitors in the genetic toxicology testing market. Testing for genetic toxicity has a variety of uses in the cosmetics, food, pharmaceutical, and biotech industries.

The requirement for genetic toxicology information is predicted to increase due to the increased medication research and discovery as well as the expanding usage of pharmacogenomics. This is because it can evaluate the substances that can cause chromosomal damage or genetic alterations. A significant growth factor in the genetic toxicity testing field is also the development of facilities and the availability of funding globally.

COVID - 19 Impact Analysis

Due to lockdowns that have halted manufacturing operations and enforced travel restrictions, affecting the transit of shipments, the rapid expansion of COVID-19 has resulted in a lack of medical equipment and supplies. COVID-19 has not severely affected the availability of raw materials used in genetic toxicology, with the exception of transportation-related delays brought on by travel restrictions and labor scarcity difficulties. Toxicology research was being conducted to comprehend the virus mutation. Similar to this, many researchers used genotoxic to evaluate how well medications worked on the COVID-19 virus. Therefore, it can be said that the pandemic had a positive impact on the genetic toxicology testing market.

Market Growth Factors

Rising investments in pharmaceutical R&D by companies

By raising the adoption of substances in the preclinical phases, R&D operations primarily aim to raise the overall likelihood of acceptance of Phase I therapeutic candidates. In the initial stages of medication development, intense R&D activities are carried out to accomplish this. The necessity for genetic toxicology research is consequently increased. Before a medicine enters the pricey clinical stages, higher R&D expenditures in the early phases of drug products are also anticipated to enhance the usage of in vivo toxicity techniques.

Increasing demand for humanized methods of in vivo testing including animals

More and more biomedical research applications use humanized mice as test subjects. Professors at Yale University and the Jackson Laboratory (US) were awarded a three-year grant in 2017 to perform advanced research on humanized MISTRG models for understanding the biology of human melanoma along with identifying therapeutic targets. The Connecticut Bioscience Innovation Fund (CBIF) awarded the Jackson Laboratory and Yale University (US) a grant in the amount of USD 700,000 in November 2018. This award supported scientific collaboration to create humanized mouse models that correctly reflect how people react to disease and cancer treatments.

Market Restraining Factors

Insufficient verified in vitro models for complex endpoint research

Given that human proteins and antibodies make over half of the novel medications created, autoimmune disease and immunological activation are crucial endpoints for drug development. These medicinal compounds can only yet be tested in animal models. The use of in vitro genetic toxicology testing techniques does not permit the assessment of the response induced within a body following secondary infection. These techniques can't assess how well a body recovers in response to short-term versus long-term immunosuppression.

Product Outlook

Based on product, the genetic toxicology testing market is classified into reagents & consumables, assays, and services. The service segment procured the largest revenue share in the genetic toxicology testing market in 2021. The segment expansion is being fuelled by Contract Research Organizations' (CROs') growing strategic ambitions through investment in this sector. The rising scope of services in the epidermis and genetic toxicological testing is another factor fuelling the service sector. For instance, in order to meet the growing demand around the world, Gentronix announced that the scope of its services in the field of cutaneous toxicity will be expanding.

Type Outlook

On the basis of type, the genetic toxicology testing market is bifurcated into In Vitro and In Vivo. The in vivo segment procured a significant revenue share in the genetic toxicology testing market in 2021. An essential component of medical research generally is in vivo testing, particularly in clinical trials. Studies conducted in living organisms (in vivo) offer useful knowledge about a substance's effects or the progression of a disease. Clinical trials and animal studies are the two main categories of in vivo testing.

Application Outlook

By application, the genetic toxicology testing market is segmented into pharmaceutical & biotechnology, food industry, cosmetics industry, and other. The pharmaceutical and biotechnology segment witnessed the maximum revenue share in the genetic toxicology testing market in 2021. It is projected that one of the driving forces behind the rise will be the extensive utilization of genotoxicity testing in medicine development and research. Testing for genetic toxicity is done at the preclinical stage. Additionally, it is predicted that the biotechnology and pharmaceutical sector will increase at a fast pace as well. Given that testing is necessary for all quantities of medications and substances.

Regional Outlook

Region-wise, the genetic toxicology testing market is analysed across North America, Europe, Asia Pacific and LAMEA. The North American region witnessed the highest revenue share in the genetic toxicology testing market in 2021. The dominance in the region can be due to rising medication development and significant pipeline spending. Additionally, the presence of important actors in the region makes genotoxicology testing more accessible for local pharmaceutical and biotech firms. The significant share of this industry is due to the growth of structure-based medication designs, rising financing for life sciences research, high R&D costs in the biopharmaceutical industry, and the burgeoning uptake of cutting-edge techniques in North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific Group, Jubilant Pharmova Limited., Syngene International Limited, Gentronix Ltd., Inotiv Inc., Creative Bioarray and MB Research Laboratories.

Strategies deployed in Genetic Toxicology Testing Market

Feb-2022: Eurofins Clinical Testing Lux Sarl, a subsidiary of Eurofins Scientific acquired Genetic Testing Service, (Gentis), the market leader in specialized genetic analysis in Vietnam. With the acquisition, Eurofins focused on expanding its reach in Asia and complemented its worldwide network of clinical diagnostics laboratories working on technical and advanced genetic testing.

Jan-2022: Inotiv acquired Integrated Laboratory Systems, a portfolio company of Sier Capital Partners. Through the acquisition, Inotiv aimed to diversify the company's in vivo and in vitro toxicology services, comprising of prominent pathology and toxicology expertise. The acquisition increased the company's services into genomics, bioinformatics, and computational toxicology which further extended its market reach and created effective new cross-selling possibilities.

Sep-2021: Labcorp took over operating assets and intellectual property (IP) of the autoimmune business unit of Myriad Genetics, together with Vectra rheumatoid arthritis (RA) assay. The inclusion of Vectra testing abilities to Labcorp products' range presented the tremendous potential for the company to develop the test's availability and make Labcorp a single-source diagnostics solution for RA providers.

Aug-2021: Inotiv announced the acquisition of Gateway Pharmacology Laboratories, a preclinical contract research organization specializing in cardiovascular pharmacology studies. Following this acquisition, Inotiv augmented its array of in vivo abilities and integrated laboratory support assistance to include cardiovascular and renal pharmacology.

Jul-2021: Gentronix took over Big Blue transgenic mutation assay models by Bioreliance, the largest provider of outsourcing services focused on the rapidly growing biologics sector of the pharmaceutical industry. Through this acquisition, Gentronix aimed to double its revenues and augment its genetic toxicology capabilities in vitro skin and in vitro ocular toxicity testing.

Jun-2021: Charles River Laboratories acquired Vigene Biosciences, a premier, a gene therapy contract development and manufacturing organization. Through the acquisition, Charles River focused on augmenting its extensive cell and gene therapy range by utilizing the gene therapy expertise of Vigene Biosciences. The increased portfolio span incorporated each of the major CDMO platforms - cell therapy, viral vector, and plasmid DNA production.

Jan-2021: Charles River Laboratories partnered with Cypre, a biotechnology company that utilizes 3D hydrogel technology to advance the knowledge of the tumor microenvironment and predict therapeutic usefulness. This partnership helped the former company's clients with access to Falcon-X, Cypre's proprietary 3D tumor model platform. Moreover, the partnership broadened Charles River's 3D in vitro testing services to further optimize immuno-oncological methods for its clients.

Jan-2019: Charles River Laboratories formed an agreement with Toxys, a company that provides innovative in vitro toxicity screening solutions. Under the agreement, CRL focused on providing ToxTracker, a range of assays that enable rapid carcinogenicity toxicity hazard identification in novel and existing drugs, chemicals, and other substances in North America. The agreement equipped CRL's client base with the utilization of the ToxTracker assay that can assist in mitigating the risk of regulatory rejection by illustrating the exact mechanism of genotoxicity.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Services
  • Reagents & Consumables
  • Assays

By Type

  • In Vitro
  • In Vivo

By Application

  • Pharmaceutical & Biotechnology
  • Food Industry
  • Cosmetics Industry
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Charles River Laboratories International, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific Group
  • Jubilant Pharmova Limited.
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv Inc.
  • Creative Bioarray
  • MB Research Laboratories

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Genetic Toxicology Testing Market, by Product
    • 1.4.2 Global Genetic Toxicology Testing Market, by Type
    • 1.4.3 Global Genetic Toxicology Testing Market, by Application
    • 1.4.4 Global Genetic Toxicology Testing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Genetic Toxicology Testing Market

Chapter 4. Global Genetic Toxicology Testing Market by Product

  • 4.1 Global Services Market by Region
  • 4.2 Global Reagents & Consumables Market by Region
  • 4.3 Global Assays Market by Region

Chapter 5. Global Genetic Toxicology Testing Market by Type

  • 5.1 Global In Vitro Market by Region
  • 5.2 Global In Vivo Market by Region

Chapter 6. Global Genetic Toxicology Testing Market by Application

  • 6.1 Global Pharmaceutical & Biotechnology Market by Region
  • 6.2 Global Food Industry Market by Region
  • 6.3 Global Cosmetics Industry Market by Region
  • 6.4 Global Others Market by Region

Chapter 7. Global Genetic Toxicology Testing Market by Region

  • 7.1 North America Genetic Toxicology Testing Market
    • 7.1.1 North America Genetic Toxicology Testing Market by Product
      • 7.1.1.1 North America Services Market by Country
      • 7.1.1.2 North America Reagents & Consumables Market by Country
      • 7.1.1.3 North America Assays Market by Country
    • 7.1.2 North America Genetic Toxicology Testing Market by Type
      • 7.1.2.1 North America In Vitro Market by Country
      • 7.1.2.2 North America In Vivo Market by Country
    • 7.1.3 North America Genetic Toxicology Testing Market by Application
      • 7.1.3.1 North America Pharmaceutical & Biotechnology Market by Country
      • 7.1.3.2 North America Food Industry Market by Country
      • 7.1.3.3 North America Cosmetics Industry Market by Country
      • 7.1.3.4 North America Others Market by Country
    • 7.1.4 North America Genetic Toxicology Testing Market by Country
      • 7.1.4.1 US Genetic Toxicology Testing Market
        • 7.1.4.1.1 US Genetic Toxicology Testing Market by Product
        • 7.1.4.1.2 US Genetic Toxicology Testing Market by Type
        • 7.1.4.1.3 US Genetic Toxicology Testing Market by Application
      • 7.1.4.2 Canada Genetic Toxicology Testing Market
        • 7.1.4.2.1 Canada Genetic Toxicology Testing Market by Product
        • 7.1.4.2.2 Canada Genetic Toxicology Testing Market by Type
        • 7.1.4.2.3 Canada Genetic Toxicology Testing Market by Application
      • 7.1.4.3 Mexico Genetic Toxicology Testing Market
        • 7.1.4.3.1 Mexico Genetic Toxicology Testing Market by Product
        • 7.1.4.3.2 Mexico Genetic Toxicology Testing Market by Type
        • 7.1.4.3.3 Mexico Genetic Toxicology Testing Market by Application
      • 7.1.4.4 Rest of North America Genetic Toxicology Testing Market
        • 7.1.4.4.1 Rest of North America Genetic Toxicology Testing Market by Product
        • 7.1.4.4.2 Rest of North America Genetic Toxicology Testing Market by Type
        • 7.1.4.4.3 Rest of North America Genetic Toxicology Testing Market by Application
  • 7.2 Europe Genetic Toxicology Testing Market
    • 7.2.1 Europe Genetic Toxicology Testing Market by Product
      • 7.2.1.1 Europe Services Market by Country
      • 7.2.1.2 Europe Reagents & Consumables Market by Country
      • 7.2.1.3 Europe Assays Market by Country
    • 7.2.2 Europe Genetic Toxicology Testing Market by Type
      • 7.2.2.1 Europe In Vitro Market by Country
      • 7.2.2.2 Europe In Vivo Market by Country
    • 7.2.3 Europe Genetic Toxicology Testing Market by Application
      • 7.2.3.1 Europe Pharmaceutical & Biotechnology Market by Country
      • 7.2.3.2 Europe Food Industry Market by Country
      • 7.2.3.3 Europe Cosmetics Industry Market by Country
      • 7.2.3.4 Europe Others Market by Country
    • 7.2.4 Europe Genetic Toxicology Testing Market by Country
      • 7.2.4.1 Germany Genetic Toxicology Testing Market
        • 7.2.4.1.1 Germany Genetic Toxicology Testing Market by Product
        • 7.2.4.1.2 Germany Genetic Toxicology Testing Market by Type
        • 7.2.4.1.3 Germany Genetic Toxicology Testing Market by Application
      • 7.2.4.2 UK Genetic Toxicology Testing Market
        • 7.2.4.2.1 UK Genetic Toxicology Testing Market by Product
        • 7.2.4.2.2 UK Genetic Toxicology Testing Market by Type
        • 7.2.4.2.3 UK Genetic Toxicology Testing Market by Application
      • 7.2.4.3 France Genetic Toxicology Testing Market
        • 7.2.4.3.1 France Genetic Toxicology Testing Market by Product
        • 7.2.4.3.2 France Genetic Toxicology Testing Market by Type
        • 7.2.4.3.3 France Genetic Toxicology Testing Market by Application
      • 7.2.4.4 Russia Genetic Toxicology Testing Market
        • 7.2.4.4.1 Russia Genetic Toxicology Testing Market by Product
        • 7.2.4.4.2 Russia Genetic Toxicology Testing Market by Type
        • 7.2.4.4.3 Russia Genetic Toxicology Testing Market by Application
      • 7.2.4.5 Spain Genetic Toxicology Testing Market
        • 7.2.4.5.1 Spain Genetic Toxicology Testing Market by Product
        • 7.2.4.5.2 Spain Genetic Toxicology Testing Market by Type
        • 7.2.4.5.3 Spain Genetic Toxicology Testing Market by Application
      • 7.2.4.6 Italy Genetic Toxicology Testing Market
        • 7.2.4.6.1 Italy Genetic Toxicology Testing Market by Product
        • 7.2.4.6.2 Italy Genetic Toxicology Testing Market by Type
        • 7.2.4.6.3 Italy Genetic Toxicology Testing Market by Application
      • 7.2.4.7 Rest of Europe Genetic Toxicology Testing Market
        • 7.2.4.7.1 Rest of Europe Genetic Toxicology Testing Market by Product
        • 7.2.4.7.2 Rest of Europe Genetic Toxicology Testing Market by Type
        • 7.2.4.7.3 Rest of Europe Genetic Toxicology Testing Market by Application
  • 7.3 Asia Pacific Genetic Toxicology Testing Market
    • 7.3.1 Asia Pacific Genetic Toxicology Testing Market by Product
      • 7.3.1.1 Asia Pacific Services Market by Country
      • 7.3.1.2 Asia Pacific Reagents & Consumables Market by Country
      • 7.3.1.3 Asia Pacific Assays Market by Country
    • 7.3.2 Asia Pacific Genetic Toxicology Testing Market by Type
      • 7.3.2.1 Asia Pacific In Vitro Market by Country
      • 7.3.2.2 Asia Pacific In Vivo Market by Country
    • 7.3.3 Asia Pacific Genetic Toxicology Testing Market by Application
      • 7.3.3.1 Asia Pacific Pharmaceutical & Biotechnology Market by Country
      • 7.3.3.2 Asia Pacific Food Industry Market by Country
      • 7.3.3.3 Asia Pacific Cosmetics Industry Market by Country
      • 7.3.3.4 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific Genetic Toxicology Testing Market by Country
      • 7.3.4.1 China Genetic Toxicology Testing Market
        • 7.3.4.1.1 China Genetic Toxicology Testing Market by Product
        • 7.3.4.1.2 China Genetic Toxicology Testing Market by Type
        • 7.3.4.1.3 China Genetic Toxicology Testing Market by Application
      • 7.3.4.2 Japan Genetic Toxicology Testing Market
        • 7.3.4.2.1 Japan Genetic Toxicology Testing Market by Product
        • 7.3.4.2.2 Japan Genetic Toxicology Testing Market by Type
        • 7.3.4.2.3 Japan Genetic Toxicology Testing Market by Application
      • 7.3.4.3 India Genetic Toxicology Testing Market
        • 7.3.4.3.1 India Genetic Toxicology Testing Market by Product
        • 7.3.4.3.2 India Genetic Toxicology Testing Market by Type
        • 7.3.4.3.3 India Genetic Toxicology Testing Market by Application
      • 7.3.4.4 South Korea Genetic Toxicology Testing Market
        • 7.3.4.4.1 South Korea Genetic Toxicology Testing Market by Product
        • 7.3.4.4.2 South Korea Genetic Toxicology Testing Market by Type
        • 7.3.4.4.3 South Korea Genetic Toxicology Testing Market by Application
      • 7.3.4.5 Singapore Genetic Toxicology Testing Market
        • 7.3.4.5.1 Singapore Genetic Toxicology Testing Market by Product
        • 7.3.4.5.2 Singapore Genetic Toxicology Testing Market by Type
        • 7.3.4.5.3 Singapore Genetic Toxicology Testing Market by Application
      • 7.3.4.6 Malaysia Genetic Toxicology Testing Market
        • 7.3.4.6.1 Malaysia Genetic Toxicology Testing Market by Product
        • 7.3.4.6.2 Malaysia Genetic Toxicology Testing Market by Type
        • 7.3.4.6.3 Malaysia Genetic Toxicology Testing Market by Application
      • 7.3.4.7 Rest of Asia Pacific Genetic Toxicology Testing Market
        • 7.3.4.7.1 Rest of Asia Pacific Genetic Toxicology Testing Market by Product
        • 7.3.4.7.2 Rest of Asia Pacific Genetic Toxicology Testing Market by Type
        • 7.3.4.7.3 Rest of Asia Pacific Genetic Toxicology Testing Market by Application
  • 7.4 LAMEA Genetic Toxicology Testing Market
    • 7.4.1 LAMEA Genetic Toxicology Testing Market by Product
      • 7.4.1.1 LAMEA Services Market by Country
      • 7.4.1.2 LAMEA Reagents & Consumables Market by Country
      • 7.4.1.3 LAMEA Assays Market by Country
    • 7.4.2 LAMEA Genetic Toxicology Testing Market by Type
      • 7.4.2.1 LAMEA In Vitro Market by Country
      • 7.4.2.2 LAMEA In Vivo Market by Country
    • 7.4.3 LAMEA Genetic Toxicology Testing Market by Application
      • 7.4.3.1 LAMEA Pharmaceutical & Biotechnology Market by Country
      • 7.4.3.2 LAMEA Food Industry Market by Country
      • 7.4.3.3 LAMEA Cosmetics Industry Market by Country
      • 7.4.3.4 LAMEA Others Market by Country
    • 7.4.4 LAMEA Genetic Toxicology Testing Market by Country
      • 7.4.4.1 Brazil Genetic Toxicology Testing Market
        • 7.4.4.1.1 Brazil Genetic Toxicology Testing Market by Product
        • 7.4.4.1.2 Brazil Genetic Toxicology Testing Market by Type
        • 7.4.4.1.3 Brazil Genetic Toxicology Testing Market by Application
      • 7.4.4.2 Argentina Genetic Toxicology Testing Market
        • 7.4.4.2.1 Argentina Genetic Toxicology Testing Market by Product
        • 7.4.4.2.2 Argentina Genetic Toxicology Testing Market by Type
        • 7.4.4.2.3 Argentina Genetic Toxicology Testing Market by Application
      • 7.4.4.3 UAE Genetic Toxicology Testing Market
        • 7.4.4.3.1 UAE Genetic Toxicology Testing Market by Product
        • 7.4.4.3.2 UAE Genetic Toxicology Testing Market by Type
        • 7.4.4.3.3 UAE Genetic Toxicology Testing Market by Application
      • 7.4.4.4 Saudi Arabia Genetic Toxicology Testing Market
        • 7.4.4.4.1 Saudi Arabia Genetic Toxicology Testing Market by Product
        • 7.4.4.4.2 Saudi Arabia Genetic Toxicology Testing Market by Type
        • 7.4.4.4.3 Saudi Arabia Genetic Toxicology Testing Market by Application
      • 7.4.4.5 South Africa Genetic Toxicology Testing Market
        • 7.4.4.5.1 South Africa Genetic Toxicology Testing Market by Product
        • 7.4.4.5.2 South Africa Genetic Toxicology Testing Market by Type
        • 7.4.4.5.3 South Africa Genetic Toxicology Testing Market by Application
      • 7.4.4.6 Nigeria Genetic Toxicology Testing Market
        • 7.4.4.6.1 Nigeria Genetic Toxicology Testing Market by Product
        • 7.4.4.6.2 Nigeria Genetic Toxicology Testing Market by Type
        • 7.4.4.6.3 Nigeria Genetic Toxicology Testing Market by Application
      • 7.4.4.7 Rest of LAMEA Genetic Toxicology Testing Market
        • 7.4.4.7.1 Rest of LAMEA Genetic Toxicology Testing Market by Product
        • 7.4.4.7.2 Rest of LAMEA Genetic Toxicology Testing Market by Type
        • 7.4.4.7.3 Rest of LAMEA Genetic Toxicology Testing Market by Application

Chapter 8. Company Profiles

  • 8.1 Thermo Fisher Scientific, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
  • 8.2 Eurofins Scientific Group
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional Analysis
    • 8.2.4 Recent strategies and developments:
      • 8.2.4.1 Acquisition and Mergers:
  • 8.3 Laboratory Corporation of America Holdings
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental Analysis
    • 8.3.4 Recent strategies and developments:
      • 8.3.4.1 Acquisition and Mergers:
  • 8.4 Charles River Laboratories International, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Recent strategies and developments:
      • 8.4.4.1 Partnerships, Collaborations, and Agreements:
      • 8.4.4.2 Acquisition and Mergers:
  • 8.5 Jubilant Pharmova Limited
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expenses
  • 8.6 Syngene International Limited
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
  • 8.7 Gentronix Ltd.
    • 8.7.1 Company Overview
    • 8.7.2 Recent strategies and developments:
      • 8.7.2.1 Acquisition and Mergers:
  • 8.8 Inotiv, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Acquisition and Mergers:
  • 8.9 Creative Bioarray
    • 8.9.1 Company Overview
  • 8.10. MB Research Laboratories
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 2 Global Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 3 Global Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 4 Global Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 5 Global Services Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Services Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Reagents & Consumables Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Reagents & Consumables Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Assays Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Assays Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 12 Global Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 13 Global In Vitro Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global In Vitro Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global In Vivo Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global In Vivo Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 18 Global Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 19 Global Pharmaceutical & Biotechnology Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Pharmaceutical & Biotechnology Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Food Industry Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Food Industry Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Cosmetics Industry Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Cosmetics Industry Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Genetic Toxicology Testing Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Genetic Toxicology Testing Market by Region, 2022 - 2028, USD Million
  • TABLE 29 North America Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 30 North America Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 31 North America Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 32 North America Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 33 North America Services Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Services Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Reagents & Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Reagents & Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 40 North America Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 41 North America In Vitro Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America In Vitro Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America In Vivo Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America In Vivo Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 46 North America Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 47 North America Pharmaceutical & Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Pharmaceutical & Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Food Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Food Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Cosmetics Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Cosmetics Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Genetic Toxicology Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Genetic Toxicology Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 57 US Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 58 US Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 59 US Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 60 US Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 61 US Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 62 US Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 63 US Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 64 Canada Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 65 Canada Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 66 Canada Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 67 Canada Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 68 Canada Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 69 Canada Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 70 Canada Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 71 Canada Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 72 Mexico Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 73 Mexico Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 74 Mexico Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 75 Mexico Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 76 Mexico Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 77 Mexico Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 78 Mexico Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 79 Mexico Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 80 Rest of North America Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 81 Rest of North America Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 82 Rest of North America Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 83 Rest of North America Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 84 Rest of North America Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 85 Rest of North America Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 86 Rest of North America Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 87 Rest of North America Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 88 Europe Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 89 Europe Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 90 Europe Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 91 Europe Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 92 Europe Services Market by Country, 2018 - 2021, USD Million
  • TABLE 93 Europe Services Market by Country, 2022 - 2028, USD Million
  • TABLE 94 Europe Reagents & Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 95 Europe Reagents & Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 96 Europe Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 97 Europe Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 98 Europe Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 99 Europe Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 100 Europe In Vitro Market by Country, 2018 - 2021, USD Million
  • TABLE 101 Europe In Vitro Market by Country, 2022 - 2028, USD Million
  • TABLE 102 Europe In Vivo Market by Country, 2018 - 2021, USD Million
  • TABLE 103 Europe In Vivo Market by Country, 2022 - 2028, USD Million
  • TABLE 104 Europe Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 105 Europe Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 106 Europe Pharmaceutical & Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 107 Europe Pharmaceutical & Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 108 Europe Food Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 109 Europe Food Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 110 Europe Cosmetics Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 111 Europe Cosmetics Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 112 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 113 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 114 Europe Genetic Toxicology Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 115 Europe Genetic Toxicology Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 116 Germany Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 117 Germany Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 118 Germany Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 119 Germany Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 120 Germany Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 121 Germany Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 122 Germany Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 123 Germany Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 124 UK Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 125 UK Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 126 UK Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 127 UK Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 128 UK Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 129 UK Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 130 UK Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 131 UK Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 132 France Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 133 France Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 134 France Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 135 France Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 136 France Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 137 France Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 138 France Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 139 France Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 140 Russia Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 141 Russia Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 142 Russia Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 143 Russia Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 144 Russia Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 145 Russia Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 146 Russia Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 147 Russia Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 148 Spain Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 149 Spain Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 150 Spain Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 151 Spain Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 152 Spain Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 153 Spain Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 154 Spain Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 155 Spain Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 156 Italy Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 157 Italy Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 158 Italy Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 159 Italy Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 160 Italy Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 161 Italy Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 162 Italy Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 163 Italy Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 164 Rest of Europe Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 165 Rest of Europe Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 166 Rest of Europe Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 167 Rest of Europe Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 168 Rest of Europe Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 169 Rest of Europe Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 170 Rest of Europe Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 171 Rest of Europe Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 172 Asia Pacific Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 173 Asia Pacific Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 174 Asia Pacific Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 175 Asia Pacific Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 176 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
  • TABLE 177 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
  • TABLE 178 Asia Pacific Reagents & Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 179 Asia Pacific Reagents & Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 180 Asia Pacific Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 181 Asia Pacific Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 182 Asia Pacific Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 183 Asia Pacific Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 184 Asia Pacific In Vitro Market by Country, 2018 - 2021, USD Million
  • TABLE 185 Asia Pacific In Vitro Market by Country, 2022 - 2028, USD Million
  • TABLE 186 Asia Pacific In Vivo Market by Country, 2018 - 2021, USD Million
  • TABLE 187 Asia Pacific In Vivo Market by Country, 2022 - 2028, USD Million
  • TABLE 188 Asia Pacific Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 189 Asia Pacific Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 190 Asia Pacific Pharmaceutical & Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 191 Asia Pacific Pharmaceutical & Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 192 Asia Pacific Food Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 193 Asia Pacific Food Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 194 Asia Pacific Cosmetics Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 195 Asia Pacific Cosmetics Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 196 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 197 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 198 Asia Pacific Genetic Toxicology Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 199 Asia Pacific Genetic Toxicology Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 200 China Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 201 China Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 202 China Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 203 China Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 204 China Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 205 China Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 206 China Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 207 China Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 208 Japan Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 209 Japan Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 210 Japan Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 211 Japan Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 212 Japan Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 213 Japan Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 214 Japan Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 215 Japan Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 216 India Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 217 India Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 218 India Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 219 India Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 220 India Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 221 India Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 222 India Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 223 India Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 224 South Korea Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 225 South Korea Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 226 South Korea Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 227 South Korea Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 228 South Korea Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 229 South Korea Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 230 South Korea Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 231 South Korea Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 232 Singapore Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 233 Singapore Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 234 Singapore Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 235 Singapore Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 236 Singapore Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 237 Singapore Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 238 Singapore Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 239 Singapore Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 240 Malaysia Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 241 Malaysia Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 242 Malaysia Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 243 Malaysia Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 244 Malaysia Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 245 Malaysia Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 246 Malaysia Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 247 Malaysia Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 248 Rest of Asia Pacific Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 249 Rest of Asia Pacific Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 250 Rest of Asia Pacific Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 251 Rest of Asia Pacific Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 252 Rest of Asia Pacific Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 253 Rest of Asia Pacific Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 254 Rest of Asia Pacific Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 255 Rest of Asia Pacific Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 256 LAMEA Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 257 LAMEA Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 258 LAMEA Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 259 LAMEA Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 260 LAMEA Services Market by Country, 2018 - 2021, USD Million
  • TABLE 261 LAMEA Services Market by Country, 2022 - 2028, USD Million
  • TABLE 262 LAMEA Reagents & Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 263 LAMEA Reagents & Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 264 LAMEA Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 265 LAMEA Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 266 LAMEA Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 267 LAMEA Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 268 LAMEA In Vitro Market by Country, 2018 - 2021, USD Million
  • TABLE 269 LAMEA In Vitro Market by Country, 2022 - 2028, USD Million
  • TABLE 270 LAMEA In Vivo Market by Country, 2018 - 2021, USD Million
  • TABLE 271 LAMEA In Vivo Market by Country, 2022 - 2028, USD Million
  • TABLE 272 LAMEA Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 273 LAMEA Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 274 LAMEA Pharmaceutical & Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 275 LAMEA Pharmaceutical & Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 276 LAMEA Food Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 277 LAMEA Food Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 278 LAMEA Cosmetics Industry Market by Country, 2018 - 2021, USD Million
  • TABLE 279 LAMEA Cosmetics Industry Market by Country, 2022 - 2028, USD Million
  • TABLE 280 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 281 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 282 LAMEA Genetic Toxicology Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 283 LAMEA Genetic Toxicology Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 284 Brazil Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 285 Brazil Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 286 Brazil Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 287 Brazil Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 288 Brazil Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 289 Brazil Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 290 Brazil Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 291 Brazil Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 292 Argentina Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 293 Argentina Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 294 Argentina Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 295 Argentina Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 296 Argentina Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 297 Argentina Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 298 Argentina Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 299 Argentina Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 300 UAE Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 301 UAE Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 302 UAE Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 303 UAE Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 304 UAE Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 305 UAE Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 306 UAE Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 307 UAE Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 308 Saudi Arabia Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 309 Saudi Arabia Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 310 Saudi Arabia Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 311 Saudi Arabia Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 312 Saudi Arabia Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 313 Saudi Arabia Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 314 Saudi Arabia Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 315 Saudi Arabia Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 316 South Africa Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 317 South Africa Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 318 South Africa Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 319 South Africa Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 320 South Africa Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 321 South Africa Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 322 South Africa Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 323 South Africa Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 324 Nigeria Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 325 Nigeria Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 326 Nigeria Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 327 Nigeria Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 328 Nigeria Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 329 Nigeria Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 330 Nigeria Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 331 Nigeria Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 332 Rest of LAMEA Genetic Toxicology Testing Market, 2018 - 2021, USD Million
  • TABLE 333 Rest of LAMEA Genetic Toxicology Testing Market, 2022 - 2028, USD Million
  • TABLE 334 Rest of LAMEA Genetic Toxicology Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 335 Rest of LAMEA Genetic Toxicology Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 336 Rest of LAMEA Genetic Toxicology Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 337 Rest of LAMEA Genetic Toxicology Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 338 Rest of LAMEA Genetic Toxicology Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 339 Rest of LAMEA Genetic Toxicology Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 340 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 341 Key Information - Eurofins Scientific Group
  • TABLE 342 Key Information - Laboratory Corporation of America holdings
  • TABLE 343 key information - Charles River Laboratories International, Inc.
  • TABLE 344 Key Information - Jubilant Pharmova Limited
  • TABLE 345 Key Information - Syngene International Limited
  • TABLE 346 Key Information - Gentronix Ltd.
  • TABLE 347 Key Information - INOTIV, INC.
  • TABLE 348 Key Information - Creative Bioarray
  • TABLE 349 Key Information - MB Research Laboratories

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Genetic Toxicology Testing Market Share by Product, 2021
  • FIG 3 Global Genetic Toxicology Testing Market Share by Product, 2028
  • FIG 4 Global Genetic Toxicology Testing Market by Product, 2018 - 2028, USD Million
  • FIG 5 Global Genetic Toxicology Testing Market Share by Type, 2021
  • FIG 6 Global Genetic Toxicology Testing Market Share by Type, 2028
  • FIG 7 Global Genetic Toxicology Testing Market by Type, 2018 - 2028, USD Million
  • FIG 8 Global Genetic Toxicology Testing Market Share by Application, 2021
  • FIG 9 Global Genetic Toxicology Testing Market Share by Application, 2028
  • FIG 10 Global Genetic Toxicology Testing Market by Application, 2018 - 2028, USD Million
  • FIG 11 Global Genetic Toxicology Testing Market Share by Region, 2021
  • FIG 12 Global Genetic Toxicology Testing Market Share by Region, 2028
  • FIG 13 Global Genetic Toxicology Testing Market by Region, 2018 - 2028, USD Million
  • FIG 14 Recent strategies and developments: Charles River Laboratories International, Inc.